Xponance Inc. Lowers Position in CME Group Inc. (NASDAQ:CME)

Xponance Inc. trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 2.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,533 shares of the financial services provider’s stock after selling 1,059 shares during the quarter. Xponance Inc.’s holdings in CME Group were worth $9,738,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. grew its holdings in CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after purchasing an additional 48 shares during the period. Capital Advisors Ltd. LLC grew its stake in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after acquiring an additional 48 shares during the period. Lantz Financial LLC increased its holdings in CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after acquiring an additional 49 shares in the last quarter. Lester Murray Antman dba SimplyRich raised its position in CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 50 shares during the period. Finally, Greystone Financial Group LLC lifted its holdings in CME Group by 1.6% during the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock valued at $691,000 after purchasing an additional 52 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Trading Up 1.3 %

NASDAQ CME opened at $215.86 on Tuesday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The stock has a market capitalization of $77.72 billion, a P/E ratio of 24.56, a PEG ratio of 8.85 and a beta of 0.55. The firm’s 50-day moving average is $208.23 and its two-hundred day moving average is $207.38. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter last year, the company posted $2.30 EPS. On average, sell-side analysts anticipate that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s payout ratio is 52.33%.

Insider Activity at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CME. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Barclays lifted their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Piper Sandler reissued an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research note on Tuesday, August 20th. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Finally, Keefe, Bruyette & Woods raised their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $209.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.